TABLE 1.

FDA‐approved and off‐label antimalarial indications for dermatological conditions

FDA approved: Lupus erythematous
Off‐label:
Photosensitivity dermatoses: Dermatomyositis Chronic actinic dermatitis Polymorphous light eruption Porphyria cutanea tarda Solar urticaria Granulomatous dermatoses: Sarcoidosis Granuloma annulare Interstitial granulomatous dermatitis Annular elastolytic giant cell granuloma Panniculitis: Panniculitis Chronic erythema nodosum Lupus panniculitis	Lymphocytic infiltrates: Lymphocytoma Lymphocytic infiltrate of Jessner Other dermatoses: Morphea Oral lichen planus Psoriatic arthritis Urticarial vasculitis Chronic ulcerative stomatitis Reticular erythematous mucinosis Pemphigus foliaceus Atopic dermatitis Localized scleroderma Follicular mucinosis

Abbreviation: FDA, Food and Drug Administration.